When it comes to the calendar of months dedicated to raising awareness of illnesses or medical conditions, a few may come to mind. October is for raising awareness of breast cancer, May is for mental ...

Experts discuss the role of multidisciplinary teams, gene expression patterns, rare disease drug designation, and education gaps in managing desmoid tumors, emphasizing the need for comprehensive care ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...

FOG-001 received fast track designation after early study results showed tumor shrinkage in all evaluable patients with desmoid tumors. The U.S. Food and Drug Administration (FDA) has granted fast ...

Discover how medical institutions provide education on desmoid tumors, ensuring patient referrals and expanding access to innovative therapies. This is a video synopsis/summary of a Peer Exchange ...

STAMFORD, Conn., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with ...

A phase 3 clinical trial (research study) of a targeted therapy called nirogacestat has found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as ...

In the GRAFITI trial at a median follow-up of 33.7 months, about 30% of patients started some form of active treatment following AS, reported Anne-Rose W. Schut, a PhD candidate at Erasmus Medical ...

Nirogacestat significantly improved PFS compared with placebo among patients with progressing desmoid tumors, according to phase 3 study results presented at ESMO Congress. Perspectives from Andrew S.

Phase I Trial of Imexon in Patients With Advanced Malignancy This study compared a large series of desmoid patients treated at a single institution to a previously published series from the same ...

Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer Desmoid tumors ...